mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
-0.087 |
0.04 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.05 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |